1252479
1197205
1197139
1193723
CDIA Annual Report 2019
CDIA just released its 2019 report, showcasing activities conducted after the first funding cycle. CDIA provides top-class research and capacity building in the field of NCDs as well as ongoing policy support and strategic advocacy.
Time To Get Serious About NCDs
Non-communicable diseases are one of the major health and development challenges of the 21st Century, in terms of both the human suffering they cause and the adverse effects they have on universal sustainable development.
CDIA researchers win big grant for NCD research
A collaboration of researchers, including CDIA members, has been awarded a substantial grant of €7.5 million over five years to fight non-communicable diseases (NCDs) in sub-Saharan Africa.
Dr Zelra Malan (left) with co-supervisor Dr Katherine Everett-Murphy
CDIA research helps to upskill primary healthcare providers
Studies by a Chronic Diseases Initiative for Africa (CDIA) researcher have shed light on how patients can be better educated about living a healthier lifestyle and contributed to a vital training programme for healthcare professionals.

News

Thursday, 24 June 2021
Family doctors are the key to improving primary health care in communities

Countries that have well developed primary health care systems are known to have better health outcomes, fewer people in hospital , increased patient satisfaction and lower costs, says Bob Mash.

Publication Date:
Mon, 31 Oct 2016 - 15:45
Why Is There No Funding For Non-Communicable Diseases?

Non-communicable diseases (NCDs) – including cancers, cardiovascular disease, diabetes, mental illness, and respiratory conditions – have come to dominate the global burden of death and disability, yet attract less than 2% of all global health funding. 

Publication Date:
Mon, 31 Oct 2016 - 15:15
Reducing the Role of the Food, Tobacco, and Alcohol Industries in Noncommunicable Disease Risk in South Africa

Noncommunicable diseases (NCDs) impose a growing burden on the health, economy, and development of South Africa.

Publication Date:
Fri, 29 Apr 2016 - 14:15
Increased risk of dysglycaemia in south africans with HIV; Especially those on protease inhibitors

Comparing dysglycaemia prevalence (impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or diabetes) in HIV-infected persons, stratified by antiretroviral therapy (ART), with a community-based survey (CBS) in Cape Town, South Africa.

Publication Date:
Sat, 12 Mar 2016 - 14:30

Pages